Schildkraut J J, Orsulak P J, Schatzberg A F, Herzog J M
Schizophr Bull. 1980;6(2):220-5. doi: 10.1093/schbul/6.2.220.
This article summarizes findings from a series of studies that examined platelet monoamine oxidase (MAO) activity in patients with nonaffective schizophrenic disorders and schizophrenia-related depressions. The findings indicate that mean platelet MAO activity was not different from control values in the subgroup of nonaffective schizophrenic disorders without auditory hallucinations (that is, the S-1 subgroup). However, mean platelet MAO activity was reduced in the subgroup of nonaffective schizophrenic disorders characterized by the presence of auditory hallucinations often occurring in conjunction with paranoid features (that is, the S-2 subgroup). Moreover, we found that mean platelet MAO activity was increased in schizophrenia-related depressions characterized by histories of chronic asocial, eccentric, or bizarre behavior.
本文总结了一系列研究的结果,这些研究检测了非情感性精神分裂症障碍患者和精神分裂症相关抑郁症患者的血小板单胺氧化酶(MAO)活性。研究结果表明,在无幻听的非情感性精神分裂症障碍亚组(即S-1亚组)中,血小板MAO平均活性与对照值无差异。然而,在以伴有偏执特征的幻听为特征的非情感性精神分裂症障碍亚组(即S-2亚组)中,血小板MAO平均活性降低。此外,我们发现,以慢性社交障碍、行为古怪或怪异为病史特征的精神分裂症相关抑郁症患者,其血小板MAO平均活性升高。